US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist

0.887
+0.041+4.84%

Close Nov 6 16:00 ET

111.10MMarket Cap-844P/E (TTM)

Karyopharm Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-35.90%133.53M

-35.75%152.12M

-42.94%148.58M

-31.13%191.44M

40.39%208.32M

38.58%236.77M

26.82%260.38M

21.59%277.97M

-Cash and cash equivalents

66.83%72.83M

4.80%84.77M

-63.56%30.63M

-61.36%52.23M

-38.82%43.66M

-1.65%80.89M

-45.15%84.06M

-29.02%135.19M

-Short-term investments

-63.14%60.7M

-56.79%67.35M

-33.11%117.95M

-2.50%139.21M

113.76%164.66M

75.93%155.87M

238.72%176.32M

274.20%142.78M

Receivables

-16.20%31.78M

17.70%38M

-11.70%31.08M

-42.74%26.96M

38.17%37.92M

37.48%32.28M

40.85%35.2M

109.30%47.09M

-Accounts receivable

-16.20%31.78M

17.70%38M

-11.70%31.08M

-42.74%26.96M

38.17%37.92M

37.48%32.28M

40.85%35.2M

109.30%47.09M

Inventory

50.47%4.67M

-5.34%3.48M

-27.65%2.77M

-27.96%3.04M

-26.92%3.11M

5.82%3.67M

-1.21%3.83M

2.87%4.22M

Restricted cash

-93.94%33K

-94.36%32K

-45.74%459K

-37.97%660K

-49.54%545K

-50.52%567K

-16.57%846K

-83.24%1.06M

Other current assets

10.59%14.75M

-17.59%14.91M

-15.35%15.48M

-40.40%11.81M

-67.89%13.33M

-58.40%18.1M

-55.77%18.28M

41.19%19.82M

Total current assets

-29.81%184.76M

-28.43%208.54M

-37.73%198.37M

-33.20%233.92M

18.21%263.22M

20.18%291.38M

15.19%318.54M

27.05%350.16M

Non current assets

Net PPE

-43.80%3.08M

-37.33%3.8M

-32.77%4.45M

-33.82%4.88M

-30.90%5.48M

-28.70%6.06M

-26.89%6.63M

-22.81%7.38M

-Gross PPE

-43.80%3.08M

-37.33%3.8M

-32.77%4.45M

-18.36%11.45M

-30.90%5.48M

-28.70%6.06M

-26.89%6.63M

-10.20%14.02M

-Accumulated depreciation

----

1.20%-6.57M

----

-9.71%-6.65M

Other non current assets

30.57%1.64M

323.26%1.64M

158.36%1.64M

158.29%1.64M

100.64%1.26M

-93.00%387K

-92.49%634K

-96.86%633K

Total non current assets

-29.93%4.72M

-15.69%5.44M

-16.08%6.09M

-18.64%6.52M

-21.28%6.74M

-54.04%6.45M

-58.52%7.26M

-73.03%8.01M

Total assets

-29.81%189.48M

-28.15%213.98M

-37.24%204.46M

-32.87%240.44M

16.75%269.96M

16.12%297.83M

10.80%325.8M

17.32%358.17M

Liabilities

Current liabilities

Payables

513.26%5.78M

22.30%2.8M

-44.41%5.03M

12.62%3.12M

15.99%943K

35.01%2.29M

162.94%9.05M

72.99%2.77M

-accounts payable

513.26%5.78M

22.30%2.8M

-44.41%5.03M

12.62%3.12M

15.99%943K

35.01%2.29M

162.94%9.05M

72.99%2.77M

Current accrued expenses

-10.07%50.11M

-3.86%49.81M

16.62%54.85M

15.71%44.88M

-0.01%55.71M

-8.09%51.81M

-19.43%47.03M

-21.53%38.79M

Current debt and capital lease obligation

14.80%3.67M

14.95%3.55M

15.05%3.43M

15.18%3.31M

15.34%3.2M

17.93%3.08M

20.87%2.98M

24.01%2.87M

-Current capital lease obligation

14.80%3.67M

14.95%3.55M

15.05%3.43M

15.18%3.31M

15.34%3.2M

17.93%3.08M

20.87%2.98M

24.01%2.87M

Other current liabilities

-13.06%1.94M

-16.07%1.47M

-18.55%2.04M

-10.50%1.65M

-9.50%2.23M

-6.22%1.75M

21.23%2.5M

172.57%1.85M

Current liabilities

-0.94%61.49M

-2.22%57.62M

6.15%65.34M

5.42%69.48M

0.51%62.08M

-5.78%58.93M

-7.21%61.56M

-10.59%65.91M

Non current liabilities

Long term debt and capital lease obligation

9.30%190.59M

9.77%192.09M

-1.48%173.01M

-1.42%173.71M

-1.35%174.37M

-1.29%175M

-1.22%175.62M

-1.16%176.2M

-Long term debt

11.65%190.59M

12.10%191.13M

0.48%171.13M

0.48%170.92M

0.48%170.7M

0.47%170.5M

0.48%170.31M

0.48%170.11M

-Long term capital lease obligation

--0

-78.78%955K

-64.52%1.88M

-54.26%2.79M

-46.55%3.67M

-40.66%4.5M

-35.92%5.31M

-32.02%6.1M

Non current deferred liabilities

-44.52%73.5M

-44.62%73.5M

-0.18%132.48M

-0.39%132.48M

-0.21%132.72M

Derivative product liabilities

--17.36M

--18.63M

----

Other non current liabilities

333.05%6.18M

75.81%4.28M

137.97%2.58M

--978K

--1.43M

--2.44M

--1.09M

----

Total non current liabilities

-6.70%287.63M

-6.98%288.5M

-0.44%308.07M

-0.57%307.17M

-0.48%308.28M

-0.04%310.15M

-0.44%309.42M

-0.75%308.92M

Total liabilities

-5.73%349.12M

-6.22%346.12M

0.66%373.41M

0.48%376.64M

-0.31%370.36M

-1.00%369.08M

-1.63%370.97M

-2.64%374.83M

Shareholders'equity

Share capital

8.33%13K

0.00%12K

50.00%12K

-common stock

8.33%13K

0.00%12K

50.00%12K

-Preferred stock

--0

Retained earnings

-6.05%-1.53B

-6.37%-1.5B

-10.62%-1.52B

-10.65%-1.49B

-10.71%-1.45B

-11.16%-1.41B

-12.95%-1.38B

-14.02%-1.34B

Paid-in capital

2.06%1.37B

2.15%1.37B

1.70%1.36B

1.74%1.35B

15.41%1.35B

16.21%1.34B

17.28%1.33B

20.85%1.33B

Gains losses not affecting retained earnings

70.08%-222K

22.73%-605K

-23.63%-518K

74.76%-161K

1.33%-742K

-45.54%-783K

-581.61%-419K

-434.03%-638K

Total stockholders'equity

-59.02%-159.65M

-85.46%-132.14M

-274.01%-168.96M

-717.76%-136.21M

28.43%-100.4M

38.76%-71.25M

45.63%-45.17M

79.09%-16.66M

Total equity

-59.02%-159.65M

-85.46%-132.14M

-274.01%-168.96M

-717.76%-136.21M

28.43%-100.4M

38.76%-71.25M

45.63%-45.17M

79.09%-16.66M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-35.90%133.53M	-35.75%152.12M	-42.94%148.58M	-31.13%191.44M	-31.13%191.44M	40.39%208.32M	38.58%236.77M	26.82%260.38M	21.59%277.97M	21.59%277.97M
-Cash and cash equivalents	66.83%72.83M	4.80%84.77M	-63.56%30.63M	-61.36%52.23M	-61.36%52.23M	-38.82%43.66M	-1.65%80.89M	-45.15%84.06M	-29.02%135.19M	-29.02%135.19M
-Short-term investments	-63.14%60.7M	-56.79%67.35M	-33.11%117.95M	-2.50%139.21M	-2.50%139.21M	113.76%164.66M	75.93%155.87M	238.72%176.32M	274.20%142.78M	274.20%142.78M
Receivables	-16.20%31.78M	17.70%38M	-11.70%31.08M	-42.74%26.96M	-42.74%26.96M	38.17%37.92M	37.48%32.28M	40.85%35.2M	109.30%47.09M	109.30%47.09M
-Accounts receivable	-16.20%31.78M	17.70%38M	-11.70%31.08M	-42.74%26.96M	-42.74%26.96M	38.17%37.92M	37.48%32.28M	40.85%35.2M	109.30%47.09M	109.30%47.09M
Inventory	50.47%4.67M	-5.34%3.48M	-27.65%2.77M	-27.96%3.04M	-27.96%3.04M	-26.92%3.11M	5.82%3.67M	-1.21%3.83M	2.87%4.22M	2.87%4.22M
Restricted cash	-93.94%33K	-94.36%32K	-45.74%459K	-37.97%660K	-37.97%660K	-49.54%545K	-50.52%567K	-16.57%846K	-83.24%1.06M	-83.24%1.06M
Other current assets	10.59%14.75M	-17.59%14.91M	-15.35%15.48M	-40.40%11.81M	-40.40%11.81M	-67.89%13.33M	-58.40%18.1M	-55.77%18.28M	41.19%19.82M	41.19%19.82M
Total current assets	-29.81%184.76M	-28.43%208.54M	-37.73%198.37M	-33.20%233.92M	-33.20%233.92M	18.21%263.22M	20.18%291.38M	15.19%318.54M	27.05%350.16M	27.05%350.16M
Non current assets
Net PPE	-43.80%3.08M	-37.33%3.8M	-32.77%4.45M	-33.82%4.88M	-33.82%4.88M	-30.90%5.48M	-28.70%6.06M	-26.89%6.63M	-22.81%7.38M	-22.81%7.38M
-Gross PPE	-43.80%3.08M	-37.33%3.8M	-32.77%4.45M	-18.36%11.45M	-18.36%11.45M	-30.90%5.48M	-28.70%6.06M	-26.89%6.63M	-10.20%14.02M	-10.20%14.02M
-Accumulated depreciation	----	----	----	1.20%-6.57M	1.20%-6.57M	----	----	----	-9.71%-6.65M	-9.71%-6.65M
Other non current assets	30.57%1.64M	323.26%1.64M	158.36%1.64M	158.29%1.64M	158.29%1.64M	100.64%1.26M	-93.00%387K	-92.49%634K	-96.86%633K	-96.86%633K
Total non current assets	-29.93%4.72M	-15.69%5.44M	-16.08%6.09M	-18.64%6.52M	-18.64%6.52M	-21.28%6.74M	-54.04%6.45M	-58.52%7.26M	-73.03%8.01M	-73.03%8.01M
Total assets	-29.81%189.48M	-28.15%213.98M	-37.24%204.46M	-32.87%240.44M	-32.87%240.44M	16.75%269.96M	16.12%297.83M	10.80%325.8M	17.32%358.17M	17.32%358.17M
Liabilities
Current liabilities
Payables	513.26%5.78M	22.30%2.8M	-44.41%5.03M	12.62%3.12M	12.62%3.12M	15.99%943K	35.01%2.29M	162.94%9.05M	72.99%2.77M	72.99%2.77M
-accounts payable	513.26%5.78M	22.30%2.8M	-44.41%5.03M	12.62%3.12M	12.62%3.12M	15.99%943K	35.01%2.29M	162.94%9.05M	72.99%2.77M	72.99%2.77M
Current accrued expenses	-10.07%50.11M	-3.86%49.81M	16.62%54.85M	15.71%44.88M	15.71%44.88M	-0.01%55.71M	-8.09%51.81M	-19.43%47.03M	-21.53%38.79M	-21.53%38.79M
Current debt and capital lease obligation	14.80%3.67M	14.95%3.55M	15.05%3.43M	15.18%3.31M	15.18%3.31M	15.34%3.2M	17.93%3.08M	20.87%2.98M	24.01%2.87M	24.01%2.87M
-Current capital lease obligation	14.80%3.67M	14.95%3.55M	15.05%3.43M	15.18%3.31M	15.18%3.31M	15.34%3.2M	17.93%3.08M	20.87%2.98M	24.01%2.87M	24.01%2.87M
Other current liabilities	-13.06%1.94M	-16.07%1.47M	-18.55%2.04M	-10.50%1.65M	-10.50%1.65M	-9.50%2.23M	-6.22%1.75M	21.23%2.5M	172.57%1.85M	172.57%1.85M
Current liabilities	-0.94%61.49M	-2.22%57.62M	6.15%65.34M	5.42%69.48M	5.42%69.48M	0.51%62.08M	-5.78%58.93M	-7.21%61.56M	-10.59%65.91M	-10.59%65.91M
Non current liabilities
Long term debt and capital lease obligation	9.30%190.59M	9.77%192.09M	-1.48%173.01M	-1.42%173.71M	-1.42%173.71M	-1.35%174.37M	-1.29%175M	-1.22%175.62M	-1.16%176.2M	-1.16%176.2M
-Long term debt	11.65%190.59M	12.10%191.13M	0.48%171.13M	0.48%170.92M	0.48%170.92M	0.48%170.7M	0.47%170.5M	0.48%170.31M	0.48%170.11M	0.48%170.11M
-Long term capital lease obligation	--0	-78.78%955K	-64.52%1.88M	-54.26%2.79M	-54.26%2.79M	-46.55%3.67M	-40.66%4.5M	-35.92%5.31M	-32.02%6.1M	-32.02%6.1M
Non current deferred liabilities	-44.52%73.5M	-44.62%73.5M	-0.18%132.48M	-0.18%132.48M	-0.18%132.48M	-0.39%132.48M	-0.21%132.72M	-0.21%132.72M	-0.21%132.72M	-0.21%132.72M
Derivative product liabilities	--17.36M	--18.63M	----	----	----	----	----	----	----	----
Other non current liabilities	333.05%6.18M	75.81%4.28M	137.97%2.58M	--978K	--978K	--1.43M	--2.44M	--1.09M	----	----
Total non current liabilities	-6.70%287.63M	-6.98%288.5M	-0.44%308.07M	-0.57%307.17M	-0.57%307.17M	-0.48%308.28M	-0.04%310.15M	-0.44%309.42M	-0.75%308.92M	-0.75%308.92M
Total liabilities	-5.73%349.12M	-6.22%346.12M	0.66%373.41M	0.48%376.64M	0.48%376.64M	-0.31%370.36M	-1.00%369.08M	-1.63%370.97M	-2.64%374.83M	-2.64%374.83M
Shareholders'equity
Share capital	8.33%13K	8.33%13K	0.00%12K	0.00%12K	0.00%12K	50.00%12K	50.00%12K	50.00%12K	50.00%12K	50.00%12K
-common stock	8.33%13K	8.33%13K	0.00%12K	0.00%12K	0.00%12K	50.00%12K	50.00%12K	50.00%12K	50.00%12K	50.00%12K
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-6.05%-1.53B	-6.37%-1.5B	-10.62%-1.52B	-10.65%-1.49B	-10.65%-1.49B	-10.71%-1.45B	-11.16%-1.41B	-12.95%-1.38B	-14.02%-1.34B	-14.02%-1.34B
Paid-in capital	2.06%1.37B	2.15%1.37B	1.70%1.36B	1.74%1.35B	1.74%1.35B	15.41%1.35B	16.21%1.34B	17.28%1.33B	20.85%1.33B	20.85%1.33B
Gains losses not affecting retained earnings	70.08%-222K	22.73%-605K	-23.63%-518K	74.76%-161K	74.76%-161K	1.33%-742K	-45.54%-783K	-581.61%-419K	-434.03%-638K	-434.03%-638K
Total stockholders'equity	-59.02%-159.65M	-85.46%-132.14M	-274.01%-168.96M	-717.76%-136.21M	-717.76%-136.21M	28.43%-100.4M	38.76%-71.25M	45.63%-45.17M	79.09%-16.66M	79.09%-16.66M
Total equity	-59.02%-159.65M	-85.46%-132.14M	-274.01%-168.96M	-717.76%-136.21M	-717.76%-136.21M	28.43%-100.4M	38.76%-71.25M	45.63%-45.17M	79.09%-16.66M	79.09%-16.66M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data